Evidence map›Paper›PMID 34435041›Full record

ArticleBioMed research international2021

Correlation of Neuroimaging Findings with Clinical Presentation and Laboratory Data in Patients with COVID-19: A Single-Center Study.

Seyhmus Kavak, Mehmet Serdar Yildirim, Rojhat Altındag, Yilmaz Mertsoy, Mehmet Fuat Alakus, Mehmet Diyaddin Guleken, Safak Kaya

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Awareness on D-dimer assay among dental students.Journal of advanced pharmaceutical technology & research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Seyhmus KavakDepartment of Radiology, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.ORCID https://orcid.org/0000-0002-5426-7478
Mehmet Serdar YildirimDepartment of Internal Medicine, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Rojhat AltındagDepartment of Cardiology, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Yilmaz MertsoyDepartment of Orthopedics and Traumatology, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Mehmet Fuat AlakusDepartment of Ophthalmology, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Mehmet Diyaddin GulekenDepartment of Psychiatry, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Safak KayaDepatment of Infectious Diseases and Clinical Microbiology, Health Sciences University, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Sağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was aimed at revealing neuroimaging findings in COVID-19 patients and at discussing their relationship with epidemiological data and some laboratory parameters.

resultsWhen the acute/subacute thromboembolism group and neuroimaging findings were compared in terms of negative group, presence of comorbid disease, D-dimer level, and lymphocyte count in COVID-19 patients, a statistically significant difference was found (

conclusionAcute thromboembolic events are common in patients with COVID-19 due to a potentially increased procoagulant process. Neurological evaluation and, if necessary, detailed neuroimaging should be performed, especially in cases with high D-dimer levels.

Indexed as

AdolescentAdultAgedAged, 80 and overBrainCOVID-19COVID-19 TestingFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedNeuroimagingOccipital LobeRetrospective StudiesSARS-CoV-2Fibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID34435041
PMCPMC8380509
OpenAlexW3194987385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.